Literature DB >> 23908348

Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study.

Rosita Zakeri1, Alanna M Chamberlain, Véronique L Roger, Margaret M Redfield.   

Abstract

BACKGROUND: In patients with heart failure and preserved ejection fraction (HFpEF), atrial fibrillation (AF) may predate, concur with, or develop after HFpEF diagnosis. We sought to define the temporal relationship between AF and HFpEF, to identify factors associated with AF, and to determine the prognostic impact of prevalent and incident AF in HFpEF. METHOD AND
RESULTS: From 1983 to 2010, 939 Olmsted County, Minnesota, residents (age, 77±12 years; 61% female) newly diagnosed with HFpEF (EF ≥0.50) were evaluated. Baseline rhythm classification included prior AF (>3 months before HFpEF diagnosis), concurrent AF (±3 months), or sinus rhythm. Incident AF (>3 months after HFpEF diagnosis) and all-cause mortality were ascertained through February 2012. Prior AF (29%) and concurrent AF (23%) were associated with older age, higher brain-type natriuretic peptide, and larger left atrial volume index at HFpEF diagnosis compared with sinus rhythm. Of HFpEF patients in sinus rhythm at diagnosis, 32% developed AF over a median follow-up of 3.7 years (interquartile range, 1.5-6.7 years; 69 events per 1000 person-years). Age and diastolic dysfunction were positively and statin use was inversely associated with incident AF. With no AF used as the referent, prior or concurrent AF (combined hazard ratio, 1.3; 95% confidence interval, 1.0-1.6; P=0.03) and incident AF, modeled as a time-dependent covariate (hazard ratio, 2.1; 95% confidence interval, 1.4-3.0; P<0.001), were independently associated with death after adjustment for pertinent covariates.
CONCLUSIONS: AF occurs in two thirds of HFpEF patients at some point in the natural history and confers a poor prognosis. Further study is required to determine whether intervention for AF may improve outcomes or if statin use can prevent AF in HFpEF.

Entities:  

Keywords:  atrial fibrillation; heart failure, diastolic; population; prognosis

Mesh:

Year:  2013        PMID: 23908348      PMCID: PMC3910441          DOI: 10.1161/CIRCULATIONAHA.113.001475

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  46 in total

1.  Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.

Authors:  Anique Ducharme; Karl Swedberg; Marc A Pfeffer; Alain Cohen-Solal; Christopher B Granger; Aldo P Maggioni; Eric L Michelson; John J V McMurray; Lars Olsson; Jean L Rouleau; James B Young; Bertil Olofsson; Margareta Puu; Salim Yusuf
Journal:  Am Heart J       Date:  2006-07       Impact factor: 4.749

2.  Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.

Authors:  Giuseppe Patti; Massimo Chello; Dario Candura; Vincenzo Pasceri; Andrea D'Ambrosio; Elvio Covino; Germano Di Sciascio
Journal:  Circulation       Date:  2006-09-25       Impact factor: 29.690

3.  Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial.

Authors:  C N Pellegrini; E Vittinghoff; F Lin; S B Hulley; G M Marcus
Journal:  Heart       Date:  2009-01-28       Impact factor: 5.994

4.  Rosuvastatin in older patients with systolic heart failure.

Authors:  John Kjekshus; Eduard Apetrei; Vivencio Barrios; Michael Böhm; John G F Cleland; Jan H Cornel; Peter Dunselman; Cândida Fonseca; Assen Goudev; Peer Grande; Lars Gullestad; Ake Hjalmarson; Jaromir Hradec; András Jánosi; Gabriel Kamenský; Michel Komajda; Jerzy Korewicki; Timo Kuusi; François Mach; Vyacheslav Mareev; John J V McMurray; Naresh Ranjith; Maria Schaufelberger; Johan Vanhaecke; Dirk J van Veldhuisen; Finn Waagstein; Hans Wedel; John Wikstrand
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

5.  Effect of atrial fibrillation on long-term survival in patients hospitalised for heart failure with preserved ejection fraction.

Authors:  Dan Rusinaru; Laurent Leborgne; Marcel Peltier; Christophe Tribouilloy
Journal:  Eur J Heart Fail       Date:  2008-05-23       Impact factor: 15.534

6.  Rhythm control versus rate control for atrial fibrillation and heart failure.

Authors:  Denis Roy; Mario Talajic; Stanley Nattel; D George Wyse; Paul Dorian; Kerry L Lee; Martial G Bourassa; J Malcolm O Arnold; Alfred E Buxton; A John Camm; Stuart J Connolly; Marc Dubuc; Anique Ducharme; Peter G Guerra; Stefan H Hohnloser; Jean Lambert; Jean-Yves Le Heuzey; Gilles O'Hara; Ole Dyg Pedersen; Jean-Lucien Rouleau; Bramah N Singh; Lynne Warner Stevenson; William G Stevenson; Bernard Thibault; Albert L Waldo
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

7.  Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials.

Authors:  Laurent Fauchier; Bertrand Pierre; Axel de Labriolle; Caroline Grimard; Noura Zannad; Dominique Babuty
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

8.  Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.

Authors:  John J V McMurray; Peter E Carson; Michel Komajda; Robert McKelvie; Michael R Zile; Agata Ptaszynska; Christoph Staiger; J Mark Donovan; Barry M Massie
Journal:  Eur J Heart Fail       Date:  2008-02       Impact factor: 15.534

9.  New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey.

Authors:  Maximo Rivero-Ayerza; Wilma Scholte Op Reimer; Mattie Lenzen; Dominic A M J Theuns; Luc Jordaens; Michel Komajda; Ferenc Follath; Karl Swedberg; John G F Cleland
Journal:  Eur Heart J       Date:  2008-05-31       Impact factor: 29.983

10.  Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.

Authors:  Renate B Schnabel; Lisa M Sullivan; Daniel Levy; Michael J Pencina; Joseph M Massaro; Ralph B D'Agostino; Christopher Newton-Cheh; Jennifer F Yamamoto; Jared W Magnani; Thomas M Tadros; William B Kannel; Thomas J Wang; Patrick T Ellinor; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

View more
  79 in total

Review 1.  Clinical Relevance of the Spectral Tissue Doppler E/e' Ratio in the Management of Patients with Atrial Fibrillation: a Comprehensive Review of the Literature.

Authors:  Stephane Arques
Journal:  J Atr Fibrillation       Date:  2018-08-31

Review 2.  Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.

Authors:  Sanjiv J Shah; Dalane W Kitzman; Barry A Borlaug; Loek van Heerebeek; Michael R Zile; David A Kass; Walter J Paulus
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

Review 3.  Patient selection in heart failure with preserved ejection fraction clinical trials.

Authors:  Jacob P Kelly; Robert J Mentz; Alexandre Mebazaa; Adriaan A Voors; Javed Butler; Lothar Roessig; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor; Carolyn S P Lam
Journal:  J Am Coll Cardiol       Date:  2015-04-28       Impact factor: 24.094

Review 4.  The pathophysiology of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug
Journal:  Nat Rev Cardiol       Date:  2014-06-24       Impact factor: 32.419

5.  Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.

Authors:  Angela B S Santos; Gabriela Querejeta Roca; Brian Claggett; Nancy K Sweitzer; Sanjiv J Shah; Inder S Anand; James C Fang; Michael R Zile; Bertram Pitt; Scott D Solomon; Amil M Shah
Journal:  Circ Heart Fail       Date:  2016-04       Impact factor: 8.790

6.  Prognostic significance of residual functional mitral regurgitation in hospitalized heart failure patients with chronic atrial fibrillation and preserved ejection fraction after medical therapies.

Authors:  Kazato Ito; Yukio Abe; Hiroyuki Watanabe; Yoshihisa Shimada; Kentaro Shibayama; Hiroki Oe; Eiichi Hyodo; Chinami Miyazaki; Yosuke Takahashi; Toshihiko Shibata; Hiroshi Ito
Journal:  J Echocardiogr       Date:  2018-12-19

Review 7.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

8.  Mechanisms of atrial fibrillation in aged rats with heart failure with preserved ejection fraction.

Authors:  Thassio Ricardo Ribeiro Mesquita; Rui Zhang; Geoffrey de Couto; Jackelyn Valle; Lizbeth Sanchez; Russell G Rogers; Kevin Holm; Weixin Liu; Eduardo Marbán; Eugenio Cingolani
Journal:  Heart Rhythm       Date:  2020-02-15       Impact factor: 6.343

9.  Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction.

Authors:  Rosita Zakeri; Gilles Moulay; Qiang Chai; Ozgur Ogut; Saad Hussain; Hiroyuki Takahama; Tong Lu; Xiao-Li Wang; Wolfgang A Linke; Hon-Chi Lee; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2016-10-10       Impact factor: 8.790

Review 10.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.